Morning Seminar August 23, 2006

Differences between DLBCL and Burkitt lymphoma.

Morning Seminar August 22, 2006

Science. 2002 Mar 15;295(5562):2097-100.

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.

Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A.

Morning Seminar August 17, 2006

Pediatr Blood Cancer. 2006 Jul;47(1):51-5.

FDG PET for the study of primary hepatic malignancies in children.

Mody RJ, Pohlen JA, Malde S, Strouse PJ, Shulkin BL.

Morning Seminar August 15, 2006

Br J Haematol. 2006 Apr;133(2):176-82.

Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents--a Berlin-Frankfurt-Munster group report.

Woessmann W, Peters C, Lenhard M, Burkhardt B, Sykora KW, Dilloo D, Kremens B, Lang P, Fuhrer M, Kuhne T, Parwaresch R, Ebell W, Reiter A.

Morning Seminar August 10, 2006

Pediatr Blood Cancer. 2005 Sep;45(3):318-23.

Pulmonary function impairment in children following hematopoietic stem cell transplantation.

Wieringa J, van Kralingen KW, Sont JK, Bresters D.

Morning Seminar August 8, 2006

Ann Oncol. 2006 Aug;17(8):1301-5.

High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours.

McTiernan A, Driver D, Michelagnoli MP, Kilby AM, Whelan JS.

Morning Seminar August 3, 2006

J Clin Oncol. 2006 Jul 1;24(19):3150-6.

Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.

Gaynon PS, Harris RE, Altman AJ, Bostrom BC, Breneman JC, Hawks R, Steele D, Zipf T, Stram DO, Villaluna D, Trigg ME.

Morning Seminar August 1, 2006

Pediatr Blood Cancer. 2005 Mar;44(3):245-50.

The 2000 Burkitt lymphoma trial in Malawi.

Hesseling P, Broadhead R, Mansvelt E, Louw M, Wessels G, Borgstein E, Schneider J, Molyneux E.